THE COST EFFECTIVENESS ANALYSIS OF THE ORAL ANTI-VIRAL TREATMENTS ALTERNATIVES FOR THE CHRONIC HEPATITIS B IN TURKEY

被引：0
|
作者：
Kockaya, G. [1 ]
Kose, A. [1 ]
Dalgic, C. [1 ]
Yenilmez, F. B. [2 ]
Ozdemir, O. [3 ]
Kucuksayrac, E. [1 ]
Tayfun, K. [1 ]
机构：
[1] Gilead Sci, Istanbul, Turkey
[2] Hacettepe Univ, Ankara, Turkey
[3] Yorum Consultancy, Istanbul, Turkey
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.823
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI26
引用
收藏
页码：A367 / A367
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey
    Kockaya, Guvenc
    Kose, Akin
    Yenilmez, Fatma Betul
    Ozdemir, Oktay
    Kucuksayrac, Ece
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
  • [2] Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey
    Guvenc Kockaya
    Akin Kose
    Fatma Betul Yenilmez
    Oktay Ozdemir
    Ece Kucuksayrac
    [J]. Cost Effectiveness and Resource Allocation, 13
  • [3] Cost-effectiveness analysis of anti-viral treatments in patients with chronic hepatitis B infection in Hong Kong
    Lam, T. P. Elegance
    Lam, Cindy L. K.
    Lai, C. L.
    Yuen, M. F.
    McGhee, Sarah
    Fong, Daniel
    Leung, Gabriel
    [J]. QUALITY OF LIFE RESEARCH, 2012, 21 : 61 - 61
  • [4] Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy
    Buti, Maria
    Riveiro-Barciela, Mar
    Esteban, Rafael
    [J]. CLINICS IN LIVER DISEASE, 2021, 25 (04) : 725 - 740
  • [5] Cost-effectiveness of oral treatments for chronic hepatitis B
    Dusheiko, Geoffrey M.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 623 - 625
  • [6] ANTI-VIRAL TREATMENT OF CHRONIC HEPATITIS C IN A PAEDIATRIC POPULATION: A COST-EFFECTIVENESS ANALYSIS
    Mernagh, P.
    Norris, S.
    Del Cuore, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A403 - A403
  • [7] Adherence to Anti-Viral Treatment for Chronic Hepatitis B
    Abu-Freha, Naim
    Abu Tailakh, Muhammad
    Fich, Alexander
    Abu Bader, Nasreen
    Shemer-Avni, Yonat
    Alsana, Farhan
    Gasper, Nava
    Abu-Kaf, Heba
    Etzion, Ohad
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 10
  • [8] Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis
    Veenstra, D. L.
    Spackman, D. E.
    Bisceglie, A.
    Kowdley, K. V.
    Gish, R. G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) : 1240 - 1252
  • [9] Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
    Singal, A. K.
    Salameh, H.
    Kuo, Y. -F.
    Fontana, R. J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (02) : 98 - 106
  • [10] Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?
    Rijckborst, V.
    Sonneveld, M. J.
    Janssen, H. L. A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) : 501 - 513
12345